#TILS $TLSA - research note:

Listing- AIM / NASDAQ
Price- 57.5p
52wk High- 162p
MC- £92.3M
Issue- 160M
FreeFloat- 40%
Director holding- 40%
IP / Tech- Foralumab, Milciclib, Anti il-6r, StemPrintER

Cont.
#TILS $TLSA - IP & Tech:

Foralumab - immunotheraputic - market size $127B (just cancer)

Milciclib - Oncology (cell regulator) - market size $176B

IL-6 inhibitor - Autoimmune & COVID-19 - market size TBD

StemPrintER - Breast Cancer Diagnostic - market size $4.64B

Cont.
#TILS $TLSA - IL-6 & Covid-19:

Study launched into TILS fully human IL-6 inhibitor in relieving covid symptoms.

Patent filed on unique inhaler delivery system.

Recent acquisition of IP with Covid applications.

Covid put TILS on the map, however,,,,,

Cont.
#TILS $TLSA - IL-6 & Covid-19:Study launched into TILS fully human IL-6 inhibitor in relieving covid symptoms.Patent filed on unique inhaler delivery system. Recent acquisition of IP with Covid applications. Covid put TILS on the map, however,,,,,Cont.
#TILS $TLSA - IL-6 & Covid-19:Study launched into TILS fully human IL-6 inhibitor in relieving covid symptoms.Patent filed on unique inhaler delivery system. Recent acquisition of IP with Covid applications. Covid put TILS on the map, however,,,,,Cont.
#TILS $TLSA - StemPrintER

You came for the covid, but will stay for the breast!

StemPrintER is a breast cancer diagnostic assay that is generating big interest lately after it emerged ASCO are minded to deem this tech best in class.

"So what?" I hear you ask. Read on.

Cont.
#TILS $TLSA - StemPrintERYou came for the covid, but will stay for the breast! StemPrintER is a breast cancer diagnostic assay that is generating big interest lately after it emerged ASCO are minded to deem this tech best in class."So what?" I hear you ask. Read on.Cont.
#TILS $TLSA - StemPrintERYou came for the covid, but will stay for the breast! StemPrintER is a breast cancer diagnostic assay that is generating big interest lately after it emerged ASCO are minded to deem this tech best in class."So what?" I hear you ask. Read on.Cont.
#TILS $TLSA - StemPrintERYou came for the covid, but will stay for the breast! StemPrintER is a breast cancer diagnostic assay that is generating big interest lately after it emerged ASCO are minded to deem this tech best in class."So what?" I hear you ask. Read on.Cont.
#TILS $TLSA - Backers:

ASCO is the leading authority in oncology. An endorsement from ASCO (especially on a diagnostic like this that DOES NOT REQUIRE FDA) is worth gold.

Further, the independent verification is said to be from the prestigious Royal Marsden.

Cont.
#TILS $TLSA - Backers:ASCO is the leading authority in oncology. An endorsement from ASCO (especially on a diagnostic like this that DOES NOT REQUIRE FDA) is worth gold.Further, the independent verification is said to be from the prestigious Royal Marsden.Cont.
#TILS $TLSA - Backers:ASCO is the leading authority in oncology. An endorsement from ASCO (especially on a diagnostic like this that DOES NOT REQUIRE FDA) is worth gold.Further, the independent verification is said to be from the prestigious Royal Marsden.Cont.
#TILS $TLSA - Inflection points

TILS holds a GM TODAY

TILS has its ASCO abstracts released MAY 13TH

TILS has the full ASCO event MAY 29TH

TILS has covid pipeline of news flow on top of this!

So what's it worth?

Cont.
#TILS $TLSA - Inflection pointsTILS holds a GM TODAYTILS has its ASCO abstracts released MAY 13THTILS has the full ASCO event MAY 29THTILS has covid pipeline of news flow on top of this!So what's it worth?Cont.
#TILS $TLSA - Inflection pointsTILS holds a GM TODAYTILS has its ASCO abstracts released MAY 13THTILS has the full ASCO event MAY 29THTILS has covid pipeline of news flow on top of this!So what's it worth?Cont.
#TILS $TLSA - what's it worth?

TILS will be addressing a $4.64 billion market.

Genomic had the best assay which generated $300M PA revenues. It was bought out by EXACT Nov19 for $2.8B.

Work out TILS P/E on $300M PA or the SP on a takeover.

PS. this tech is close to market
#TILS $TLSA - what's it worth?TILS will be addressing a $4.64 billion market. Genomic had the best assay which generated $300M PA revenues. It was bought out by EXACT Nov19 for $2.8B. Work out TILS P/E on $300M PA or the SP on a takeover. PS. this tech is close to market
#TILS $TLSA - what's it worth?TILS will be addressing a $4.64 billion market. Genomic had the best assay which generated $300M PA revenues. It was bought out by EXACT Nov19 for $2.8B. Work out TILS P/E on $300M PA or the SP on a takeover. PS. this tech is close to market
#TILS $TLSA - what's it worth?TILS will be addressing a $4.64 billion market. Genomic had the best assay which generated $300M PA revenues. It was bought out by EXACT Nov19 for $2.8B. Work out TILS P/E on $300M PA or the SP on a takeover. PS. this tech is close to market
#TILS $TLSA - RNS 06.05.2020

All resolutions passed at GM

TR1 - Morris Silverman, industry professional ups stake from 3.63% to 4.94%
#TILS $TLSA - RNS 06.05.2020All resolutions passed at GMTR1 - Morris Silverman, industry professional ups stake from 3.63% to 4.94%
#TILS $TLSA - RNS 06.05.2020All resolutions passed at GMTR1 - Morris Silverman, industry professional ups stake from 3.63% to 4.94%
You can follow @TakeAIM100.
Tip: mention @twtextapp on a Twitter thread with the keyword “unroll” to get a link to it.

Latest Threads Unrolled:
There are a lot of misconceptions about the Turkish diaspora in Germany. Since i just finished writing an essay about this topic I thought it's time to give other people
Read more
Las mejores calculadoras online en 2020A thread http://totumat.com/2020/11/26/las-mejores-calculadoras-online-en-2020/ Cuando se estudian asignaturas que requieren de cálculos complicados, nada mejor que contar con una buena calculadora.
Read more
Mitigating #ClimateChange is as much about taking up new techs as about leaving others behindMost studies focus on #coal's global downfall but another #energy tech decline is loomingRead my new
Read more